A commonly prescribed drug could be more effective than aspirin for long-term heart disease prevention. Analysis of nearly 29,000 patients with coronary artery disease (CAD) suggests the blood thinner ...
The INSPIRES, a double-blind, placebo-controlled trial, involved patients with mild ischemic stroke or high-risk TIA of presumed atherosclerotic cause who had not undergone thrombolysis or ...
People at risk of a cardiac event after a percutaneous coronary intervention (PCI) stent procedure who received long-term antiplatelet therapy with clopidogrel were 29% less likely to die than those ...
A study suggests that a certain type of blood thinner may be more effective than aspirin in preventing heart attacks and strokes in patients with a specific form of heart disease. The research also ...
CHICAGO -- For prolonged antithrombotic treatment after percutaneous coronary intervention (PCI), clopidogrel monotherapy was more effective and at least as safe as aspirin monotherapy in a high-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback